Bengaluru (Karnataka) [India], January 29: Medullary thyroid cancer (MTC) is a rare but aggressive form of cancer that originates in the thyroid gland. While it accounts for a small percentage of thyroid cancer cases, its impact can be profound, especially in individuals with a family history of the disease. Dr. Sandeep Nayak emphasizes the importance of early screening and genetic testing for individuals with a family history of MTC, as early detection can significantly improve treatment outcomes.
Dr. Nayak, the founder of MACS Clinic and a professor of Minimal Access Surgical Oncology, is a renowned surgical oncologist in India and has long been at the forefront of developing innovative treatment approaches for thyroid cancer. He advocates for genetic testing and regular screening for those with a family history of medullary thyroid cancer, as these measures can help identify at-risk individuals before symptoms even appear. Early intervention enables more effective treatment options, better surgical outcomes, and improved overall survival.
MTC often presents with no clear symptoms in its early stages, making diagnosis difficult. For patients with a family history of MTC, Dr. Nayak emphasizes the importance of regular monitoring and early screening. MTC can sometimes be linked to hereditary conditions like Multiple Endocrine Neoplasia type 2 (MEN2), a genetic disorder that increases the risk of developing MTC. Genetic testing can help identify MEN2 mutations early, allowing for proactive management and timely surgical interventions.
“For patients with a family history of thyroid cancer or MEN2, early screening is crucial,” says Dr. Nayak. “Genetic testing and regular check-ups are the keys to preventing the spread of this aggressive cancer and ensuring better treatment outcomes. If detected early, MTC can be treated effectively with surgery and other targeted therapies, reducing the risk of complications.”
Dr. Nayak’s commitment to providing state-of-the-art care for thyroid cancer patients extends beyond surgical expertise. He integrates advanced diagnostic techniques, including genetic testing, into his practice to ensure each patient receives a personalized, comprehensive treatment plan. His work focuses not just on treating the disease but on preventing its progression through early detection and targeted therapies.
Dr. Nayak continues to practice at MACS Clinic and KIMS Hospital, where he leads a multidisciplinary team delivering comprehensive, state-of-the-art cancer care.
- MACS Clinic – 96/A 3rd Main, 42nd Cross Rd, 8th Block, Jayanagar, Bengaluru, Karnataka 560070
- KIMS Bengaluru – Mahadevapura – Survey No. 36/5, Outer Ring Road, Doddanekkundi, Hobli, K.R. Puram, Mahadevapura, Bengaluru – 560037, Karnataka, India.
- KIMS Bengaluru – Electronic City – Survey No. 37 & 38, PES University EC Campus, Hosur Rd, Konappana Agrahara, Electronic City, Bengaluru – 560100, Karnataka, India.
At these centers, Dr. Nayak and his team specialize in the treatment of thyroid cancers, including medullary thyroid cancer. The clinics are equipped with the latest in medical technology, offering genetic screening, advanced surgery, and a patient-centered approach to ensure the best possible outcomes for those at risk.
About Dr. Sandeep Nayak
Dr. Sandeep Nayak is an internationally recognized surgical oncologist and the founder of MACS Clinic, Bengaluru. Known for pioneering minimally invasive and robotic cancer surgeries, he has revolutionized the surgical treatment of thyroid, colon, rectal, and head & neck cancers. As a professor, innovator, and patient advocate, Dr. Nayak continues to set new standards for cancer care in India and beyond.
